Display options
Share it on

J Int Soc Sports Nutr. 2009 May 29;6:12. doi: 10.1186/1550-2783-6-12.

Microencapsulated foods as a functional delivery vehicle for omega-3 fatty acids: a pilot study.

Journal of the International Society of Sports Nutrition

Conrad P Earnest, Molly K Hammar, Monica Munsey, Catherine R Mikus, Robert M David, J Alexander Bralley, Timothy S Church

Affiliations

  1. Pennington Biomedical Research Center, Baton Rouge, Louisiana, USA. [email protected].

PMID: 19480650 PMCID: PMC2694142 DOI: 10.1186/1550-2783-6-12

Abstract

It is well established that the ingestion of the omega-3 (N3) fatty acids docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA) positively benefit a variety of health indices. Despite these benefits the actual intake of fish derived N3 is relatively small in the United States. The primary aim of our study was to examine a technology capable of delivering omega-3 fatty acids in common foods via microencapsulation (MicroN3) in young, healthy, active participants who are at low risk for cardiovascular disease. Accordingly, we randomized 20 participants (25.4 +/- 6.2 y; 73.4 +/- 5.1 kg) to receive the double blind delivery of a placebo-matched breakfast meal (~2093 kJ) containing MicroN3 (450-550 mg EPA/DHA) during a 2-week pilot trial. Overall, we observed no differences in overall dietary macronutrient intake other than the N3 delivery during our treatment regimen. Post-test ANOVA analysis showed a significant elevation in mean (SE) plasma DHA (91.18 +/- 9.3 vs. 125.58 +/- 11.3 umol/L; P < 0.05) and a reduction in triacylglycerols (89.89 +/- 12.8 vs. 80.78 +/- 10.4 mg/dL; P < 0.05) accompanying the MicroN3 treatment that was significantly different from placebo (P < 0.05). In post study interviews, participants reported that the ingested food was well-tolerated, contained no fish taste, odor or gastrointestinal distress accompanying treatment. The use of MicroN3 foods provides a novel delivery system for the delivery of essential fatty acids. Our study demonstrates that MicroN3 foods promote the absorption of essential N3, demonstrate bioactivity within 2 weeks of ingestion and are well tolerated in young, active participants who are at low risk for cardiovascular disease.

References

  1. QJM. 2003 Jul;96(7):465-80 - PubMed
  2. Ann Epidemiol. 1995 Sep;5(5):378-85 - PubMed
  3. Poult Sci. 2003 Mar;82(3):388-94 - PubMed
  4. Circulation. 2000 Oct 31;102(18):2284-99 - PubMed
  5. Arterioscler Thromb Vasc Biol. 2003 Feb 1;23(2):e20-30 - PubMed
  6. Am J Cardiol. 2006 Aug 21;98(4A):3i-18i - PubMed
  7. Am J Clin Nutr. 1997 May;65(5 Suppl):1645S-1654S - PubMed
  8. Am J Clin Nutr. 2000 Jan;71(1 Suppl):232S-7S - PubMed
  9. Lipids. 2005 Apr;40(4):419-28 - PubMed
  10. Am J Clin Nutr. 2006 Jun;83(6 Suppl):1467S-1476S - PubMed
  11. Am J Clin Nutr. 2006 Jun;83(6 Suppl):1536S-1538S - PubMed
  12. Am J Clin Nutr. 2006 Jun;83(6 Suppl):1483S-1493S - PubMed
  13. J Lipid Res. 1997 Oct;38(10):2012-22 - PubMed
  14. Am J Clin Nutr. 1997 Apr;65(4 Suppl):1254S-1263S - PubMed
  15. Am J Clin Nutr. 2008 Jun;87(6):1977S - PubMed
  16. J Nutr. 2006 Jan;136(1):83-7 - PubMed

Publication Types